Analysis of autofluorescent retinal images and measurement of atrophic lesion growth in Stargardt disease.

Current retinal imaging techniques using scanning laser ophthalmoscopy (SLO) provide a powerful mechanism for characterizing the topographical distribution of lipofuscin fluorophores and atrophic lesions (ALs) in retinal disease. In this paper we describe a novel Edge-Flow-Driven Variational Image Segmentation analysis to measure and evaluate progressive change in the area of ALs as well as regions of hyperfluorescence (HF). The algorithm is embedded in a series of almost completely automated image processing steps that allow rapid comparison of serial images. The sensitivity of the methodology to detect change was evaluated by measuring progression of AF lesion size in a cohort of Stargardt Macular Dystrophy (STGD) patients. Fifty-two STGD subjects (mean age = 41.0 +/- 16.6 years, range 9-78 yrs) at varying stages of disease participated in this prospective study. Twenty-four of the 52 subjects presented with atrophic lesions in one or both eyes on first evaluation. For this subgroup of subjects, the mean (+/-1 sd) follow-up time was 2.92 (+0.26) years (range 0.57-3.26 years) and the mean (+/-1 sd) rate of change was found to be approximately 0.94 (+/-0.87) mm(2)/year (range 0.2-2.13 mm(2)/yr). With this methodology, progressive enlargement of AL area was detectable in as little as one year, while regions of HF generally decreased, although there was considerable variability in the appearnce of HF, presumably reflecting the combined effects of the creation or expansion of lipofuscin deposits and resorption and loss associated with retinal cell death. Our findings suggest that this methodology is sufficiently sensitive to detect change and provides a clinically relevant tool to monitor progression not only with regards to natural history, but also to evaluate the efficacy of potential therapeutic interventions in STGD. Finally, we evaluated the association between AL area and measures of rod- and cone-mediated retinal function, as assessed with electroretinography (ERG). In general, the larger the AL, the poorer the ERG response, with a greater impact of lesion size on cone- rather than rod-mediated retinal function, a finding that was expected on the basis of the location and size of the AL and the distribution of rod- and cone-photoreceptors.

[1]  Michael Unser,et al.  A pyramid approach to subpixel registration based on intensity , 1998, IEEE Trans. Image Process..

[2]  B. S. Manjunath,et al.  EdgeFlow: a technique for boundary detection and image segmentation , 2000, IEEE Trans. Image Process..

[3]  Alejandro F. Frangi,et al.  Muliscale Vessel Enhancement Filtering , 1998, MICCAI.

[4]  Xinran Liu,et al.  Isotretinoin treatment inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration. , 2004, Novartis Foundation symposium.

[5]  H. Kolb,et al.  Anatomical pathways for color vision in the human retina , 1991, Visual Neuroscience.

[6]  D. Farber,et al.  Electroretinographic evidence for altered phototransduction gain and slowed recovery from photobleaches in albino mice with a MET450 variant in RPE65. , 2003, Experimental eye research.

[7]  G. Eldred,et al.  Retinal age pigments generated by self-assembling lysosomotropic detergents , 1993, Nature.

[8]  Richard O. Duda,et al.  Pattern classification and scene analysis , 1974, A Wiley-Interscience publication.

[9]  P. Sieving,et al.  Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C Bellman,et al.  Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. , 2001, Investigative ophthalmology & visual science.

[11]  R. Radu,et al.  Characterization of Native Retinal Fluorophores Involved in Biosynthesis of A2E and Lipofuscin-associated Retinopathies* , 2006, Journal of Biological Chemistry.

[12]  A C Bird,et al.  The relationships of age changes in retinal pigment epithelium and Bruch's membrane. , 1999, Investigative ophthalmology & visual science.

[13]  D. Bok,et al.  Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases. , 2005, Investigative ophthalmology & visual science.

[14]  William M. Wells,et al.  Medical Image Computing and Computer-Assisted Intervention — MICCAI’98 , 1998, Lecture Notes in Computer Science.

[15]  S. Jockusch,et al.  A2E-epoxides Damage DNA in Retinal Pigment Epithelial Cells , 2003, The Journal of Biological Chemistry.

[16]  G. Travis,et al.  Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Weiter,et al.  Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. , 1986, Investigative ophthalmology & visual science.

[18]  Andreas Wenzel,et al.  Age-related Macular Degeneration , 2000, The Journal of Biological Chemistry.

[19]  Jens Dreyhaupt,et al.  Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD. , 2006, Investigative ophthalmology & visual science.

[20]  E. Berman,et al.  Lipofuscin of human retinal pigment epithelium. , 1980, American journal of ophthalmology.

[21]  A. Bird,et al.  Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. , 2001, Archives of ophthalmology.

[22]  E. Rodriguez-Boulan,et al.  The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K. Nakanishi,et al.  A2E, a lipofuscin fluorophore, in human retinal pigmented epithelial cells in culture. , 1999, Investigative ophthalmology & visual science.

[24]  B. S. Manjunath,et al.  Variational image segmentation using boundary functions , 1998, IEEE Trans. Image Process..

[25]  T. Sakmar,et al.  Interaction of A2E with Model Membranes. Implications to the Pathogenesis of Age-related Macular Degeneration , 2002, The Journal of general physiology.

[26]  C. Grimm,et al.  Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. , 2000, The Journal of biological chemistry.

[27]  Jens Dreyhaupt,et al.  Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. , 2007, American journal of ophthalmology.

[28]  R. Allikmets,et al.  Small molecule RPE65 antagonists limit the visual cycle and prevent lipofuscin formation. , 2006, Biochemistry.

[29]  J. Weiter,et al.  Cell loss in the aging retina. Relationship to lipofuscin accumulation and macular degeneration. , 1989, Investigative ophthalmology & visual science.

[30]  John C. Hwang,et al.  Predictive value of fundus autofluorescence for development of geographic atrophy in age-related macular degeneration. , 2006, Investigative ophthalmology & visual science.

[31]  J. Lebensohn,et al.  Retinal Structure and Colour Vision , 1947 .

[32]  B. S. Manjunath,et al.  Edgeflow-driven Variational Image Segmentation: Theory and Performance Evaluation , 2005 .

[33]  R. T. Smith,et al.  Lipofuscin and autofluorescence metrics in progressive STGD. , 2009, Investigative ophthalmology & visual science.

[34]  P. Charbel Issa,et al.  In vivo imaging of foveal sparing in geographic atrophy secondary to age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.

[35]  D. Birch,et al.  Insights into the Function of Rim Protein in Photoreceptors and Etiology of Stargardt's Disease from the Phenotype in abcr Knockout Mice , 1999, Cell.

[36]  E Taylor,et al.  Calculation of total retinal area. , 1971, The British journal of ophthalmology.

[37]  P. Gouras,et al.  Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy , 2008, Gene Therapy.

[38]  M. Boulton,et al.  RPE lipofuscin and its role in retinal pathobiology. , 2005, Experimental eye research.

[39]  F. Holz,et al.  Analysis of digital scanning laser ophthalmoscopy fundus autofluorescence images of geographic atrophy in advanced age-related macular degeneration , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.

[40]  U. Mansmann,et al.  Automated analysis of digital fundus autofluorescence images of geographic atrophy in advanced age-related macular degeneration using confocal scanning laser ophthalmoscopy (cSLO) , 2005, BMC ophthalmology.

[41]  K. Palczewski,et al.  Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents. , 2007, Annual review of pharmacology and toxicology.

[42]  R.T. Smith,et al.  A hybrid segmentation approach for geographic atrophy in fundus auto-fluorescence images for diagnosis of age-related macular degeneration , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[43]  D. Sarraf,et al.  Retinal Function in X-linked Ocular Albinism (OA1) , 2008, Current eye research.

[44]  M. Bach,et al.  ISCEV Standard for full-field clinical electroretinography (2008 update) , 2009, Documenta Ophthalmologica.